Oprah Winfrey, 71, revealed the reason she returned to taking GLP-1 drugs after taking a year-long break while voicing strong ...
Jan 13 (Reuters) - U.S. telehealth firm Ro said on Tuesday it has entered a research collaboration with drugmaker Amgen ...
Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...
NewsNation’s Elizabeth Prann spoke with nurse practitioner Yarickza Lopez about what parents should consider when it comes to ...
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations ...
The U.S. FDA on Tuesday requested Novo Nordisk (NVO) and Eli Lilly (LLY) to implement labeling changes for their blockbuster ...
Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said ...
Humana’s CenterWell pharmacy will dispense GLP-1 weight loss drugs made by Eli Lilly as part of a new program for employers ...
Howard Schools expected health care premiums to increase by 19.5% if GLP-1 coverage continued, leading to an increase of $47 ...
As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's ...
GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback